Pharmaceutical Compliance Consultancy UK
A practical programme, built to work day to day.
Our UK pharmaceutical compliance consultancy helps pharma and biotech companies design and implement practical healthcare compliance programmes. We support ABPI Code compliance and anti-bribery and anti-corruption (ABAC) controls through policies, risk assessments, training and monitoring tailored to your activities and markets.
Discuss this service
The challenge
Turn compliance policies into everyday practice
A growing portfolio, new markets and competing priorities can expose gaps between written policies and what teams actually do. Unclear approval routes, inconsistent records and reactive training make it harder to demonstrate that controls work. We help connect your framework to the activities, people and decisions it needs to govern.
Who this service is for
For compliance and legal leaders, Medical Affairs teams and business owners in pharmaceutical and biotech companies. Support can begin with a first compliance programme, a specific control gap or the improvement of an established framework.
How delivery works
We agree the scope around your activities and markets, review existing controls and prioritise the gaps. The work can combine policies and SOPs, responsibilities, risk assessments, training, monitoring and remediation. Implementation includes the approval routes and evidence requirements your teams need to use the programme in practice.
What we can take on
Healthcare Compliance Programme Design and Implementation: scope of support
Policy and SOP development
Data Protection
Risk assessment and monitoring
Gap analysis, audits and inspections
CAPA and remediation support
Compliance training
Third-party due diligence
Whistle-blowing
Grants and Funding Management
Conflict of Interest
Legal mandate mapping including ABAC and FCPA
What this gives you
A practical framework with clear ownership
Inspection-ready records and evidence
Training, monitoring and remediation connected to real risks
Why Eunomia
Expertise connected to delivery
Eunomia combines pharmaceutical compliance expertise with operational delivery. Programme design can connect to local-market support, shared-service capacity and automation, so the framework has a practical route into day-to-day work. Scope, responsibilities and handover are agreed with your team.
Meet your compliance specialists →Related case study
A consistent FMV framework across five markets
Eunomia developed a documented compensation methodology, objective tiering and rate cards for six stakeholder categories across the UK, Germany, France, Italy and Spain. The case illustrates how a defined framework can make decisions easier to explain and review.
Read the case study →How an engagement runs
From scope to working process
- 01
Scope
Agree the activities, markets and obligations in scope, and the people who own them.
- 02
Assess
Review existing policies, approvals, records and training against those obligations, and risk-rate the gaps.
- 03
Design and implement
Build or update policies, SOPs, approval routes, evidence requirements and role-based training.
- 04
Monitor and improve
Set up monitoring, CAPA and governance reporting so the programme is tested and improved in routine operation.
The rules behind this service
Frameworks we work to
A UK programme is usually assessed against both industry codes and the law. These are the main frameworks we design controls around; the right set depends on your activities and markets.
Start here
2024 ABPI Code of Practice
Took effect on 1 October 2024, with a transition period to 31 December 2024, and is administered by the PMCPA independently of the ABPI. Clause 24 addresses contracted services, including legitimate need, selection, advance contracting and remuneration reflecting fair market value.
Official source: PMCPA: 2024 ABPI CodeUK Bribery Act 2010, section 7
A commercial organisation can be liable for failing to prevent bribery by persons associated with it, such as agents and service providers. Having adequate procedures in place is a defence.
Official source: Bribery Act, s.7Failure to prevent fraud (ECCTA 2023)
The corporate offence introduced by the Economic Crime and Corporate Transparency Act 2023 has applied since 1 September 2025, and belongs in the assessment of third-party and commercial controls.
Official source: ECCTA guidanceSFO guidance on compliance programmes
Explains how the UK Serious Fraud Office assesses whether a corporate compliance programme works in practice. It is enforcement guidance, not a pharmaceutical certification standard.
Official source: SFO guidanceInformational summary, not legal advice. Sources checked September 2026.
Questions, answered
Healthcare Compliance Programme Design and Implementation FAQs
How do I set up a pharmaceutical compliance programme?
Establish governance, roles, practical policies and SOPs, approval and monitoring processes, evidence requirements and role-based training aligned to applicable obligations.
What is audit readiness?
A continuous state in which documentation, controls, evidence and governance are embedded in routine operations rather than assembled immediately before an audit.
What is included in a compliance audit?
Scope may include document review, operational testing, interviews, system walkthroughs, risk-rated findings and a practical remediation roadmap.
Can you support PMCPA readiness and remediation?
Yes. Support can assess governance, procedures, approvals, training, HCP engagement, FMV, transparency, monitoring and certification against relevant expectations.
How is an effective CAPA plan structured?
It identifies root causes, actions, accountable owners, due dates, dependencies and effectiveness checks, with progress tracked through governance.
Can compliance training be tailored?
Yes. Training can be adapted by role, market, process and system using classroom, virtual, e-learning or blended delivery with effectiveness measures.
Tell us what is on your desk.
We will listen, ask a few questions and recommend the right scope—without obligation or pressure.
Start a conversation